成大生物：累计回购约38万股

Group 1 - The company Chengda Bio announced a share buyback of approximately 380,000 shares, accounting for about 0.092% of its total share capital, with a total expenditure of approximately 10.79 million RMB [1] - The highest and lowest prices for the repurchased shares were 29.61 RMB and 27.2 RMB per share, respectively [1] - As of the report, Chengda Bio's market capitalization stands at 11.3 billion RMB [1] Group 2 - For the year 2024, the company's revenue composition is entirely from biopharmaceuticals, with a 100% share [1]